Grepafloxacin Hydrochloride | m-entrepreneurship.com

Product Name :
Grepafloxacin Hydrochloride

Search keywords :
Grepafloxacin (hydrochloride)

drugId :
null

Target Vo:
Topoisomerase IV

Target Vo Short Name :
Topoisomerase IV

Moa_Name:
Bacterial DNA gyrase inhibitors

First Approval Country :
United States

First Approval Date Filter:
1997

Origin Company_Name :
Otsuka Holdings Co Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Communicable Diseases

Termination Status :

China Termination Status :

Highest Status:
Withdrawn

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ATF6 Mouse mAb Protocol
Glofitamab supplier
HSF1 Antibody (YA896): HSF1 Antibody (YA896) is an unconjugated, approximately 57-80 kDa, rabbit-derived, anti-HSF1 (YA896) monoclonal antibody. HSF1 Antibody (YA896) can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human background without labeling.

Author: Betaine hydrochloride

Related Posts